Bladder augmentation: Complications in the pediatric population

Current Urology Reports

Volumn 8, Issue 2, 2007, Pages 152-156

  Metcalfe, Peter D ^a   Rink, Richard C ^b  

^a RILEY HOSPITAL FOR CHILDREN   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; PROTON PUMP INHIBITOR;

ANAPLASTIC CARCINOMA; BLADDER CARCINOMA; BLADDER SURGERY; DIGESTIVE SYSTEM FUNCTION DISORDER; HEMATURIA DYSURIA SYNDROME; HUMAN; INTESTINE OBSTRUCTION; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; REVIEW; TRANSITIONAL CELL CARCINOMA; URINARY TRACT DISEASE; URINARY TRACT INFECTION; AGE; BLADDER; BLADDER EXSTROPHY; CONGENITAL MALFORMATION; FEMALE; INFANT; MALE; METHODOLOGY; NEWBORN; PLASTIC SURGERY; PRESCHOOL CHILD; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME; UROGENITAL TRACT MALFORMATION; UROLOGIC SURGERY;

AGE FACTORS; BLADDER EXSTROPHY; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RECONSTRUCTIVE SURGICAL PROCEDURES; RISK ASSESSMENT; TREATMENT OUTCOME; URINARY BLADDER; UROGENITAL ABNORMALITIES; UROLOGIC SURGICAL PROCEDURES;

EID: 33847736731     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-007-0065-x     Document Type: Review

References (53)

1. •• Metcalfe PD, Cain MP, Gilley DA, et al.: What is the Need for Additional Bladder Surgery after Bladder Augmentation in Childhood? Presented at the American Association of Pediatrics Section on Urology Annual Meeting. Washington, DC; October 2005. This series is a comprehensive review of surgical complications in the largest series of pediatric bladder augmentations. The incidence and risk factors of malignancy, bladder perforation, bowel obstruction, reaugmentation, and bladder stones is discussed.
2. Mitchell ME, Piser JA: Intestinocystoplasty and total bladder replacement in children and young adults: followup in 129 cases. J Urol 1987, 138:579-584.
3. Gearhart JP, Albertsen PC, Marshall FF, Jeffs RD: Pediatric applications of augmentation cystoplasty: the Johns Hopkins experience. J Urol 1986, 136:430-432.
4. Rink R, Yerkes E, Adams M: Augmentation Cystoplasty. In Pediatric Urology. Edited by Gearhart J, Rink R, Mouriquand P. Philadelphia: WB Saunders; 2001.
5. Rink R, Hollensbe D, Adams M: Complications of augmentation in children and comparison of gastrointestinal segments. AUA Update Series. 1995, 14:122-128.
6. Leonard MP, Dharamsi N, Williot PE: Outcome of gastrocystoplasty in tertiary pediatric urology practice. J Urol 2000, 164:947-950.
7. Lytton B, Green DF: Urodynamic studies in patients undergoing bladder replacement surgery. J Urol 1989, 141:1394-1397.
8. Hedlund H, Lindstrom K, Mansson W: Dynamics of a continent caecal reservoir for urinary diversion. Br J Urol 1984, 56:366-372.
9. Berglund B, Kock NG: Volume capacity and pressure characteristics of various types of intestinal reservoirs. World J Surg 1987, 11:798-803.
10. Radomski SB, Herschorn S, Stone AR: Urodynamic comparison of ileum vs. sigmoid in augmentation cystoplasty for neurogenic bladder dysfunction. Neurourol Urodyn 1995, 14:231-237.
11. Rosen MA, Light JK: Spontaneous bladder rupture following augmentation enterocystoplasty. J Urol 1991, 146:1232-1234.
12. Slaton JW, Kropp KA: Conservative management of suspected bladder rupture after augmentation enterocystoplasty. J Urol 1994, 152:713-715.
13. Metcalfe P, Casale A, Meldrum K, et al.: Spontaneous Perforation of the Augmented Bladder. Presented at the AUA Annual Meeting. San Antonio, TX; May 2005.
14. DeFoor W, Tackett L, Minevich E, et al.: Risk factors for spontaneous bladder perforation after augmentation cystoplasty. Urology 2003, 62:737-741.
15. Bertschy C, Bawab F, Liard A, et al.: Enterocystoplasty complications in children. A study of 30 cases. Eur J Pediatr Surg 2000, 10:30-34.
16. Shekarriz B, Upadhyay J, Demirbilek S, et al.: Surgical complications of bladder augmentation: comparison between various enterocystoplasties in 133 patients. Urology 2000, 55:123-128.
17. Shokeir AA, Shamaa M, el-Mekresh MM, et al.: Late malignancy in bowel segments exposed to urine without fecal stream. Urology 1995, 46:657-661.
18. Sohn M, Fuzesi L, Deutz F, et al.: Signet ring cell carcinoma in adenomatous polyp at site of ureterosigmoidostomy 16 years after conversion to ileal conduit. J Urol 1990, 143:805-807.
19. Golomb J, Klutke CG, Lewin KJ, et al.: Bladder neoplasms associated with augmentation cystoplasty: report of 2 cases and literature review. J Urol 1989, 142:377-380.
20. Husmann DA, Spence HM: Current status of tumor of the bowel following ureterosigmoidostomy: a review. J Urol 1990, 144:607-610.
21. Filmer RB, Spencer JR: Malignancies in bladder augmentations and intestinal conduits. J Urol 1990, 143:671-678.
22. Smith P, Hardy GJ: Carcinoma occurring as a late complication of ileocystoplasty. Br J Urol 1971, 43:576-579.
23. Rink RC, Hensle TW, Kaefer M, Mitchell ME: Complications of Bladder Augmentation-Plenary Lecture. Presented at the AUA Annual Meeting. San Antonio, TX; May 2005.
24. Kalble T, Tricker AR, Friedl P, et al.: Ureterosigmoidostomy: long-term results, risk of carcinoma and etiological factors for carcinogenesis. J Urol 1990, 144:1110-1114.
25. Gittes RF: Carcinogenesis in ureterosigmoidostomy. Urol Clin North Am 1986, 13:201-205.
26. Shands C III, McDougal WS, Wright EP: Prevention of cancer at the urothelial enteric anastomotic site. J Urol 1989, 141:178-181.
27. Chiang MS, Minton JP, Clausen K, et al.: Carcinoma in a colon conduit urinary diversion. J Urol 1982, 127:1185-1187.
28. Badawi AF: Molecular and genetic events in schistosomiasis-associated human bladder cancer: role of oncogenes and tumor suppressor genes. Cancer Lett 1996, 105:123-138.
29. Nurse DE, Mundy AR: Assessment of the malignant potential of cystoplasty. Br J Urol 1989, 64:489-492.
30. Hicks RM, Ismail MM, Walters CL, et al.: Association of bacteriuria and urinary nitrosamine formation with Schistosoma haematobium infection in the Qalyub area of Egypt. Trans R Soc Trop Med Hyg 1982, 76:519-527.
31. Mirvish SS: Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 1995, 93:17-48.
32. Crissey MM, Steele GD, Gittes RF: Rat model for carcinogenesis in ureterosigmoidostomy. Science 1980, 207:1079-1080.
33. Dull BJ, Gittes RF, Goldman P: Nitrate production and phagocyte activation: differences among Sprague-Dawley, Wistar-Furth and Lewis rats. Carcinogenesis 1988, 9:625-627.
34. Wall BM, Dmochowski RR, Malecha M, et al.: Inducible nitric oxide synthase in the bladder of spinal cord injured patients with a chronic indwelling urinary catheter. J Urol 2001, 165:1457-1461.
35. •• Austen M, Kalble T: Secondary malignancies in different forms of urinary diversion using isolated gut. J Urol 2004, 172:831-838. A recent publication examining different intestinal segments and their risk of malignancy.
36. Carr LK, Herschorn S: Early development of adenocarcinoma in a young woman following augmentation cystoplasty for undiversion. J Urol 1997, 157:2255-2256.
37. Soergel TM, Cain MP, Misseri R, et al.: Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder. J Urol 2004, 172:1649-1651.
38. Singh G, Thomas DG: Bowel problems after enterocystoplasty. Br J Urol 1997, 79:328-332.
39. Herschorn S, Hewitt RJ: Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder. Urology 1998, 52:672-678.
40. Gonzales R, Cabral BPH: Rectal continence enterocystoplasty. Dial Ped Urol 1987, 10:3-4.
41. King LR: Protection of the Upper Tracts in Undiversion. In Bladder Reconstruction and Continent Urinary Diversion. Chicago: Yearbook Medical Publishers; 1987:127-153.
42. Barrington JW, Fern-Davies H, Adams RJ, et al.: Bile acid dysfunction after clam enterocystoplasty. Br J Urol 1995, 76:169-171.
43. Kropp BP, Cheng EY: Bladder Augmentation: Current and Future Techniques. In Clinical Pediatric Urology 4th edn. Edited by Belma BA, King LR, Kram SA. London: Martin Dunitz; 2002:455-490.
44. Akerlund S: Urinary diversion via the continent ileal reservoir. Functional characteristics and long-term outcome. Scand J Urol Nephrol Suppl 1989, 121:1-36.
45. Stein R, Lotz J, Andreas J, et al.: Long-term metabolic effects in patients with urinary diversion. World J Urol 1998, 16:292-297.
46. Salomon L, Lugagne PM, Herve JM, et al.: No evidence of metabolic disorders 10 to 22 years after Carney type I ileal enterocystoplasty. J Urol 1997, 157:2104-2106.
47. Chadwick Plaire J, Snodgrass WT, Grady RW, Mitchell ME: Long-term followup of the hematuria-dysuria syndrome. J Urol 2000, 164:921-923.
48. Mingin GC, Stock JA, Hanna MK: Gastrocystoplasty: long-term complications in 22 patients. J Urol 1999, 162:1122-1125.
49. Nguyen DH, Bain MA, Salmonson KL, et al.: The syndrome of dysuria and hematuria in pediatric urinary reconstruction with stomach. J Urol, 1993, 150:707-709.
50. Rink R, Renschler T, Adams M, Mitchell M: Long term follow-up of the first gastrocystoplasty series. Presented at the Annual Meeting of the European Society of Pediatric Urology. Tours, France; June 2000.
51. Dykes EH, Ransley PG: Gastrocystoplasty in children. Br J Urol: 1992, 69:91-95.
52. Reinberg Y, Manivel JC, Froemming C, Gonzalez R: Perforation of the gastric segment of an augmented bladder secondary to peptic ulcer disease. J Urol 1992, 148:369-371.
53. Austin PF, DeLeary G, Homsy YL, et al.: Long-term metabolic advantages of a gastrointestinal composite urinary reservoir. J Urol 1997, 158:1704-1707.